Long term HER2+ metastatic breast cancer survivors treated by trastuzumab: Results from the French cohort study LHORA

Abstract Purpose The LORHA study described the clinical features of patients and tumours in long-term responders from a subset of breast cancer patients who responded to 1st-line trastuzumab and without disease progression. Methods This was an ambispective, multicentre, non-interventional study cond...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Breast (Edinburgh) 2015-08, Vol.24 (4), p.376-383
Hauptverfasser:	Spano, J.-P, Beuzeboc, P, Coeffic, D, Arnould, L, Lortholary, A, Andre, F, Ferrero, J.-M
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antineoplastic Agents - administration & dosage Antineoplastic Combined Chemotherapy Protocols - administration & dosage Breast cancer Breast Neoplasms - chemistry Breast Neoplasms - drug therapy Breast Neoplasms - mortality Breast Neoplasms - pathology Disease-Free Survival Female Follow-Up Studies France Hematology, Oncology and Palliative Medicine Humans Long-term responders Lymphatic Metastasis Middle Aged Paclitaxel - administration & dosage Progression-free survival Prospective Studies Receptor, ErbB-2 Retrospective Studies Survivors Taxoids - administration & dosage Trastuzumab Trastuzumab - administration & dosage
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!